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Background: To assess the protocols of epidural analgesia versus systemic opioid-based analgesia retrospectively in
1555 thoracotomies in our thoracic centre during 2011–2013.
Methods: Pain therapy is aggressive and standardized in our thoracic centre thoughout the complete postoperative
stay. Patients receive either standardized epidural analgesia with ropivacaine + sufentanil 4–8 mls/h (500 mls bag) and
are bridged when the epidural bag is finished to a standardized controlled-release oxycodone protocol with non
opioid every 6 hours (EDA Group), or patients receive immediately postoperative standardized oral analgesic protocol
with controlled-released oxycodone and non opioid every 6 h (Opioid Group). All patients are visited daily by a pain
specialist throughout the whole stay.
Results: Data of 1555 thoracotomies from 2011–2013 were analysed, 838 patients in the EDA Group and 717 patients
in the Opioid Group. There was no difference with regard to sex or age between groups. 7.5% of patients in the EDA
Group and 13% in the Oxy Group had a preexisting pain therapy (p = 0.001). In the EDA Group epidural analgesia
was performed for 4.6 ± 1.5 days. Length of hospital stay was the same in both groups (EDA: 9.9.6 ± 4.9 vs Opioid:
9.6 ± 5.8 days). 84.7% of patients in the EDA Group and 79.1% of patients of the Oxy Group were dismissed with oral
opioid (p < 0.004). When patients were dismissed with opioid medication patients in the EDA Group were dismissed
with higher oxycodone opioid doses than patients in the Opioid Group (29.5 ± 15.2 mg vs 26.9 ± 15.2 mg, p = 0.01).
There was no difference with regard to dejection time between the two groups (EDA: 3.8 ± 2.2 days vs Opioid:
3.7 ± 1.6 days, n.s.).
Conclusion: We first present data monitoring postoperative analgesic protocols after thoracotomies throughout the
whole stay in hospital until dismission. Our retrospective data indicate that patients with epidural analgesia stay as long
in hospital as patients with systemic opioid based therapy. Patients with initial epidural analgesia are dismissed with
higher oxycodone opioid doses than patients with initial opioid based postoperative analgesia. We found no difference
in recovery of bowel function.
Study limitations: The study design is retrospectively and results might be biased.
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Pain after thoracic surgery is supposed to be one of the
most recognized pain syndrome associated with a specific
procedure [1]. To date regional anesthesia is recom-
mended for postoperative analgesia after thoracotomy
[1-4]. Besides many advantages, such as positive influence
on postoperative pulmonary morbidity [5], postoperative
epidural analgesia after thoracotomy is supposed to faster
postoperative recovery [6,7] and earlier restitution of
bowel function than with opioid-based systemic postopera-
tive analgesia [8,9]. We recently showed that an aggressive
systemic pain therapy can be very effective after anteroaxil-
lary thoracotomy [10] and that epidural analgesia is not su-
perior to systemic pain therapy with regard to establishing
neuropathic or chronic postthoracotomy pain [11].
Pain therapy is consequent and standardized in our thor-
acic centre thoughout the complete postoperative stay.
Patients receive either standardized epidural analgesia and
are bridged when the epidural bag is finished to a standard-
ized controlled-release oxycodone protocol, or patients
receive immediately postoperative standardized oral anal-
gesic protocol with controlled-released oxycodone and non
opioid every 6 h. All patients are visited daily by a pain
specialist throughout the whole stay.
The purpose of the present study was to assess the
protocols of epidural analgesia and systemic analgesia
retrospectively in 1555 thoracotomies during 2011–2013
with regard to length of postoperative hospital stay, re-
covery of bowel function and opioid dose on dismission
from hospital.
Methods
After obtaining local research committee approval
(University of Essen, Chairperson Prof. Havers) we
investigated the postoperative pain therapy protocols of
our thoracotomy patients during January 2011 until
March 2013.
All patients underwent thoracotomy in balanced or
total intravenous anesthesia. The serratus muscle was
not cut, but spread. At the end of surgery two 24 CH
soft chest tubes were placed and the thoracic cavum was
closed with three pericostal sutures.
Since 2009 pain therapy is standardized in our thoracic
center. If a thoracic epidural catheter (Braun MelsungenR)
is inserted, it is placed before induction of anesthesia at
thoracic level 5/6 or 6/7. After administering the test dose
of 3 mls bupivacaine 0.25% the continuous epidural
infusion is commenced at 4–8 mls/h (EDA Group).
The standard epidural drug combination is ropivacaine
0.2% +0.75 μg/ml sufentanil (500 mls bag).
Half an hour before the end of the surgical procedure all
patients receive 2.5 g of IV dipyrone. Dipyrone is a non-
opioid analgesic frequently used in the perioperative set-
ting in Germany. After extubating the trachea patientswithout epidural catheter receive IV piritramide at the
discretion of the anesthetist (Opioid Group). Piritramide
is an opioid commonly used in Germany with approxi-
mately 0.7 times the potency of morphine. Patients are ad-
mitted to the intensive care unit for one night and receive
1 g of dipyrone every 6 hours and IV piritramide bolus
doses when NRS (numeric rating scale, 0 = no pain up to
10 =worst pain imaginable) is >3. If patients have epidurals,
the EDA is continued at 4–6 mls/h. If epidural analgesia is
not effective, patients are switched to systemic analgesia
before dismission from intensive care unit.
After discharge from the intensive care unit the systemic
pain therapy patients receive controlled-release oxycodone/
oxycodone with naloxone (Opioid Group) 30–0–20 mg,
and from the 2nd day on ward 20–0–10 mg and IV dipyr-
one 1 g every 6 h. If the NRS is >4 IV rescue medication
(IV parecoxib 40 mg) is administered. On the ward con-
tinuous epidural analgesia is continued with the 500 mls
ropivacaine 0.2% +0.75 μg/ml sufentanil bag (EDA Group)
and IV dipyrone 1 g every 6 h. On the second day on ward
IV dipyrone 1 g is oralized to 0.5 g dipyrone 4 times daily.
The epidurals are continued on 4–8 mls/h until the 500
mls bag is finished and patients are then patients are
bridged to a standardized controlled-release oxycodone
protocol with controlled-release oxycodone/oxycodone
with naloxone 20-0-10 mg per day and oral dipyrone.
During their stay in hospital all patients are visited daily
by a pain specialized anesthetist and pain medication is
adjusted to the state of recovery. Moreover numeric rating
scale (NRS) at rest and on coughing are documented by
the nurses on the wards every 6 h, implicating that the
rescue medication (parecoxib 40 mg IV) has been admin-
istered by the nurse when NRS scores >3 at rest and >5
on coughing. Thirty min after administration of rescue
medication the NRS has to be re-assessed. If pain score
is again >5 on coughing, the nurse has to contact the
anesthetist responsible for postoperative pain therapy.
It is standardized in our thoracic centre that all patients
(both analgesic regimens) receive macrogel 13 g three
times a day orally from day 1 on ward.
We assessed our 2 analgesic protocols retrospectively
for 1555 thoracotomies from 2011–2013. Surgeons decide
on the time of discharge of patients from our hospital.
All variables were analyzed by methods of descriptive
statistics (frequency, mean ± standard deviation, range).
Differences between groups were analyzed by using the
Mann–Whitney-U test and differences in proportions were
statistically evaluated by using chi-square test. Statistical sig-
nificance was determined at the p < 0.05 level. Statistical ana-
lysis was performed by using SPSS 20.0 statistical package.
Results
Data of 1555 major thoracotomies from 2011–2013 were
analyzed, 838 patients in the EDA Group and 717







Age (years) 59.6 ± 16.7 53.6 ± 11.8 n.s.
Male gender (%) 61.1 50.0 n.s.
Hospital stay (days) 10.8 ± 3.5 9.1 ± 2.4 n.s.
Pre-existing pain therapy (%) 100 30 0.04
Dismission with oral opioid (%) 72.2 90.0 n.s.
Opiod dose after dismission
(mg)
24.2 ± 12.6 32.2 ± 16.2 n.s.
Time to first dejection (days) 4.1 ± 1.6 4.6 ± 1.7 n.s.
EDA duration (days) 4.9 ± 1.4 -
Data are presented as means ± SD.







Age (years) 61.1 ± 13.6 61.0 ± 12.2 n.s.
Male gender (%) 57.9 60.4 n.s.
Hospital stay (days) 9.9 ± 4.9 9.6 ± 5.8 n.s.
Pre-existing pain therapy (%) 7.5 13.0 <0.001
Dismission with oral opioid (%) 84.7 79.1 0.004
Opiod dose after dismission
(mg)
29.3 ± 15.2 26.9 ± 15.2 0.01
Time to first dejection (days) 3.8 ± 2.2 3.7 ± 1.6 n.s.
EDA duration (days) 4.6 ± 1.5 -
Data are presented as means ± SD.
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Group 414 patients received controlled-release oxycodone
alone, and 303 patients received controlled-release oxy-
codone combined with naloxone. The 1555 thoracoto-
mies were in detail 46 pneumonectomies (Table 2), 28
bilobectomies (Table 3), 562 lobectomies (Table 4), 213
segmental resections (Table 5), 459 wedge resections
(Table 6), 21 lung volume reductions (Table 7), 60
pleurectomies (Table 8), and 176 various procedures
(Table 9). There was no difference with regard to sex or
age between the EDA and the Opioid Group (Table 1)
except the patient population undergoing pleurectomy
(Table 8). More male patients received a pleurectomy
than female patients (90% vs 60%, p = 0.007, Table 8).
Within the 1555 thoracotomies more patients in the
Opioid Group had a preexisting pain therapy than in
the EDA Group (EDA: 7.5% vs Opioid Group13%,
p < 0.001. Table 1). Regarding the bilobectomy proced-
ure more patients in the EDA Group had a pre-existing
pain therapy than patients in the Opioid Group (100%
vs. 30%, p < 0.04, Table 3) and regarding the lobectomy
procedure, more patients in the Opioid Group than inTable 2 Characteristics of patients undergoing






Age (years) 61.1 ± 13.6 58.1 ± 16.1 n.s.
Male gender (%) 68.8 78.6 n.s.
Hospital stay (days) 13.7 ± 5.8 14.1 ± 5.8 n.s.
Pre-existing pain therapy (%) 9.4 14.3 n.s.
Dismission with oral opioid (%) 81.3 57.1 n.s.
Opiod dose after dismission
(mg)
29.0 ± 16.3 27.5 ± 18.5 n.s.
Time to first dejection (days) 4.6 ± 2.2 4.4. ± 1.9 n.s
EDA duration (days) 4.7 ± 1.6 -
Data are presented as means ± SD.the EDA Group had a pre-existing pain therapy (13.8%
vs 6.4%, p = 0.004, Table 4). In the EDA Group epidural
analgesia was performed for 4.6 ± 1.5 days (Table 1).
Hospital stay was the same in both groups (EDA: 9.9 ±
4.9 vs Oxy: 9.6 ± 5.8 days, not significant, Table 1). Only
in patients undergoing pleurectomy hospital stay was
shorter in the EDA Group (EDA Group: 10.8 ± 5.1 vs
Opioid Group 13.3 ± 8.4 days, p < 0.01, Table 8). 84.7%
of patients in the EDA Group and 79.1% of patients of
the Opioid Group were dismissed with oral opioid
(p < 0.004, Table 1), and when patients were dismissed
with opioid medication patients in the EDA Group
were dismissed with higher oxycodone opioid doses
than patients in the Opioid Group (29.5 ± 15.2 mg vs
26.9 ± 15.2 mg, p = 0.01, Table 1). There was no differ-
ence with regard to recovery of bowel function between
the two groups (EDA: 3.8 ± 2.2 days vs Oxy: 3.7 ±
1.6 days, n.s.).
Discussion
To our knowledge up to now no data are available with







Age (years) 62.1 ± 11.0 64.2 ± 10.4 0.02
Male gender (%) 58.5 54.2 n.s.
Hospital stay (days) 10.3 ± 4.9 10.6 ± 5.1 n.s.
Pre-existing pain therapy (%) 6.4 13.8 0.004
Dismission with oral opioid (%) 87.7 75.4 <0.001
Opiod dose after dismission
(mg)
28.2 ± 14.5 24.7 ± 15.1 0.02
Time to first dejection (days) 3.8 ± 1.6 4.2 ± 2.7 0.06
EDA duration (days) 4.3 ± 1.5 -
Data are presented as means ± SD.
Table 5 Characteristics of patients undergoing segmental






Age (years) 63.1 ± 11.6 62.5 ± 12.4 n.s.
Male gender (%) 56.6 51.0 n.s.
Hospital stay (days) 9.6 ± 4.4 8.9 ± 4.0 n.s.
Pre-existing pain therapy (%) 11.5 15.0 n.s.
Dismission with oral opioid (%) 84.1 82.0 n.s.
Opiod dose after dismission
(mg)
28.8 ± 15.3 27.2 ± 14.7 n.s.
Time to first dejection (days) 3.5 ± 1.6 3.6 ± 1.9 n.s.
EDA duration (days) 4.3 ± 1.3 -
Data are presented as means ± SD.
Table 7 Characteristics of patients undergoing LVR – lung






Age (years) 61.3 ± 9.2 56.7 ± 5.5 n.s.
Male gender (%) 50.0 33.3 n.s.
Hospital stay (days) 14.9 ± 5.6 15.8 ± 5.1 n.s.






28.5 ± 18.1 18.1 ± 10.3 n.s.
Time to first dejection (days) 4.6 ± 2.1 5.8 ± 2.6 n.s.
EDA duration (days) 4.5 ± 1.1 -
Data are presented as means ± SD.
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pared our two analgesic protocols in 1555 patients who
were visited daily from a pain specialist and found no
difference in recovery of bowel function (time of first
dejection). First time of dejection was overall the fourth
postoperative day. Epidural analgesia is supposed to earlier
restitution of bowel function than opioid-based systemic
postoperative analgesia [8,9]. However, these systematic
review data are based on data on abdominal surgery. Our
data cannot confirm the superiority of thoracic epidural
analgesia compared to postoperative opioids regarding
bowel function. To our knowledge, no data of randomized
controlled trials comparing epidurals and opioids on post-
operative recovery after thoracotomy are available up to
now. Our retrospective data indicate that patients with
epidural analgesia stay as long in hospital as patients with
initial systemic opioid-based therapy. There is only a mild
tendency to a shorter hospital stay in the epidural group
in patients with “smaller” surgical procedures, e.g. in the
metastasectomy subgroup or in the pleurectomy subgroup.
In all other surgical procedures such as lobectomies,Table 6 Characteristics of patients undergoing wedge
excision, metastasectomy, bullectomy, and tumor






Age (years) 58.7 ± 13.3 58.9 ± 15.1 n.s.
Male gender (%) 61.2 60.1 n.s.
Hospital stay (days) 8.4 ± 4.0 7.8 ± 3.9 0.09
Pre-existing pain therapy (%) 6.8 11.9 0.08
Dismission with oral opioid (%) 86.4 84.6 n.s.
Opiod dose after dismission
(mg)
32.4 ± 14.5 27.8 ± 14.8 0.002
Time to first dejection (days) 3.4 ± 1.6 3.4 ± 1.5 n.s.
EDA duration (days) 4.1 ± 1.3 -
Data are presented as means ± SD.bilobectomies, segmental resections with a greater resection
of parenchyma no difference in hospital stay could be de-
tected, although epidural analgesia in general is supposed
to “catalyze” recovery [6,7]. We cannot confirm these data.
Again the current evicence is not based on randomized
controlled trials. We suppose that the most influencing
factor on postoperative recovery is, assuming that effective
postoperative analgesia is provided, the surgical experience
and management of the patient. However, regarding litera-
ture there is strong evidence that pulmonary outcome is
better in thoracic surgery if patients have epidurals [5]. We
cannot confirm these data from 1998 either. We explain
our good results with the consequent analgesic protocols
for both groups until dismission from hospital and our
intensive monitoring of pain therapy until dismisssion. To
our knowledge, we first described an “aggressive” systemic
analgesic regimen in patients undergoing thoracotomy
[10,11].
More male than female patients underwent a pleurect-
omy. This is most likely due to the fact that the pleuraTable 8 Characteristics of patients undergoing






Age (years) 66.1 ± 8.2 59.8 ± 14.3 n.s.
Male gender (%) 90.0 60.0 0.007
Hospital stay (days) 10.8 ± 5.1 13.3 ± 8.4 <0.01
Pre-existing pain therapy (%) 10.0 13.3 n.s.
Dismission with oral opioid (%) 76.7 60.0 n.s.
Opiod dose after dismission
(mg)
30.7 ± 15.7 28.9 ± 18.2 n.s
Time to first dejection (days) 3.2 ± 1.1 3.7 ± 3.0 n.s.
EDA duration (days) 4.4 ± 1.4 -
Data are presented as means ± SD.
Table 9 Characteristics of patients undergoing various






Age (years) 59.3 ± 16.0 59.9 ± 15.3 n.s.
Male gender (%) 58.8 66.3 n.s.
Hospital stay (days) 9.8 ± 5.7 11.1 ± 9.4 n.s.
Pre-existing pain therapy (%) 8.8 9.2 n.s.
Dismission with oral opioid (%) 73.5 76.5 n.s.
Opiod dose after dismission
(mg)
27.7 ± 15.2 28.3 ± 16.4 n.s.
Time to first dejection (days) 3.5 ± 1.8 3.9 ± 2.2 n.s.
EDA duration (days) 4.5 ± 2.0 -
Data are presented as means ± SD.
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We assume that this difference in demographic data do
not compromise our results.
Our results regarding pre-existing pain therapy and
the choose of the analgesic regimens are quite inhomo-
geously. In all 1555 thoracotomies more patients in the
Opioid Group had a preexisting pain therapy than in the
EDA Group. Regarding the bilobectomy procedure more
patients in the EDA Group had a pre-existing pain therapy
than patients in the Opioid Group and regarding the
lobectomy procedure, more patients in the Opioid Group
than in the EDA Group had a pre-existing pain therapy.
One would have expected that more epidurals are placed
in patients with pre-existing pain therapy. However, these
results underline that our both analgesic protocols are
effective. We found that more patients in the EDA Group
than in the Opioid Group are dismissed with oral opioid,
and when patients are dismissed with opioid medication,
patients in the EDA Group are dismissed with higher opi-
oid doses than patients in the Opioid Group. This finding
underlines the fact that thoracic surgery needs multimodal
analgesic concepts not only in the first postoperative
period, but also until dismission from hospital.
We present retrospective data in our observational
study. Of course, these data might be biased. We tried to
reduce potential biases in patient selection by detailed
subgroup analysis. Patients undergoing a metastasectomy
e.g. have mostly no compromised lung function, they differ
from patients undergoing a lung volume reduction e.g. with
chronic obstructive pulmonary disease, mostly GOLD IV
with oxygen therapy.
However, there might be a tendency in our department
to recommend epidural analgesia to the patients when
the lung function is compromised and/or an extended
resection of lung parenchyma is planned. More random-
ized controlled trials with strong inclusion criteria are
needed to compare the influence of epidurals on the
outcome after thoracic surgery.Conclusion
We assessed the protocols of epidural analgesia and
systemic analgesia retrospectively in 1555 thoracotomies
during 2011–2013 with regard to length of postoperative
hospital stay, recovery of bowel function and opioid dose
on dismission from hospital. We found no superiority of
epidural analgesia. We explain our finding with the
consequent analgesic protocols for both groups until
dismission from hospital. Our findings underline the fact
that thoracic surgery needs multimodal analgesic concepts
not only in the first postoperative period, but also until
dismission from hospital.
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